Your browser doesn't support javascript.
loading
Single antigen flow beads for identification of human leukocyte antigen antibody specificities in hypersensitized patients with chronic renal failure.
Soyöz, Mustafa; Kiliçaslan-Ayna, Tülay; Özkizilcik-Koçyigit, Asli; Güleç, Derya; Pirim, Ibrahim.
Afiliação
  • Soyöz M; Department of Medical Biology and Genetics, Faculty of Medicine, Izmir Katip Çelebi University, Izmir, Turkey; Tissue Typing Laboratory, Izmir Tepecik Education and Research Hospital, Izmir, Turkey.
  • Kiliçaslan-Ayna T; Department of Medical Biology and Genetics, Faculty of Medicine, Izmir Katip Çelebi University, Izmir, Turkey; Tissue Typing Laboratory, Izmir Tepecik Education and Research Hospital, Izmir, Turkey.
  • Özkizilcik-Koçyigit A; Department of Medical Biology and Genetics, Faculty of Medicine, Izmir Katip Çelebi University, Izmir, Turkey; Tissue Typing Laboratory, Izmir Tepecik Education and Research Hospital, Izmir, Turkey.
  • Güleç D; Tissue Typing Laboratory, Izmir Tepecik Education and Research Hospital, Izmir, Turkey.
  • Pirim I; Department of Medical Biology and Genetics, Faculty of Medicine, Izmir Katip Çelebi University, Izmir, Turkey; Tissue Typing Laboratory, Izmir Tepecik Education and Research Hospital, Izmir, Turkey.
Cent Eur J Immunol ; 41(1): 93-100, 2016.
Article em En | MEDLINE | ID: mdl-27095928
ABSTRACT
AIMS OF THIS STUDY Aims of this study were to identify class I and class II antibodies in highly sensitized patients by flow cytometry single antigen bead (FC-SAB) assay and to evaluate according to donor HLA type in order to increase their kidney transplantation chance. MATERIAL AND

METHODS:

We analyzed 60 hypersensitive patients of 351 individuals, who applied to our laboratory for PRA test in November 2013-December 2014. Flow cytometric PRA screening and single antigen bead commercial kits were used for these analyses.

RESULTS:

In our study group, 19 (31.7%) of these patients were male while 41 (68.3%) patients were female. The most common acceptable antigens were A*02 (10.11%), HLA-A*23 (10.11%), HLA-B*38 (8.79%) and HLA-DRB1*03 (7.83%) in hypersensitive patients. The highest antibody reactivity on SAB was observed against HLA-A*25, HLA-B*45, HLA-DRB1*04 and HLA-DRB1*08 antigens.

CONCLUSIONS:

The determination of these acceptable and unacceptable antigens may increase their transplantation chance. Pre-transplant HLA antibody identifications provide prognostic information with respect to the determination of patients who are at increased risk of graft loss.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article